Events

ESMO 2021: AtezoTRIBE study

By ONA Editor September 23, 2021 No Comments

Highlights on atezolizumab combined with FOLFOXIRI + bevacizumab in 1st-line metastatic colorectal cancer: AtezoTRIBE study

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

About Author

Related Posts

AACR 2026: Long-term use of immunotherapy may be safe for patients with alveolar soft part sarcoma

Tumour debulking did not significantly improve survival in metastatic colorectal cancer

Pembrolizumab combination improves outcomes in platinum-resistant ovarian cancer

Leave A Reply Cancel Reply